Profilo di Laurus Labs

LAURUSLABS · NSE · INR

1971,40 ₹Variazione rispetto alla chiusura precedente: −0,64%Variazione assoluta: −12,60 ₹

Chiusura · 5 ottobre 2026

Profilo dell'azienda

Laurus Labs ha 7.059 dipendenti e ha sede a Hyderabad, India.

Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and solid oral drug products for intermediates for anti-retroviral (ARV), anti-diabetic, cardiovascular, anti-asthma, ophthalmology, oncology, and gastroenterology. It also develops and manufactures animal-origin-free recombinant proteins and cell-culture media supplements and research and development services, including drug substance development, drug product development, and biologics development. In addition, the company offers non-human ingredients; rare disease therapeutics; and finished dosages. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.

Descrizione disponibile in inglese.

Dati societari

Settore
Salute
Industria
Drug Manufacturers - Specialty & Generic
Paese
India
Sede
Jubilee Hills, 500033, Hyderabad
Dipendenti
7.059
Quotazione
LAURUSLABS · NSE
Valuta
INR